New oral spray aims to ease sore throat and canker sores without drugs

NCT ID NCT07620353

Recruiting now Symptom relief Sponsor: Laboratoires Elerte Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing an oral spray called OROSEDAL to see if it helps relieve pain from sore throats, canker sores, and other minor mouth lesions. About 124 children and adults will use the spray as prescribed and report their pain levels over 6 days. The spray works by forming a protective barrier over the sore area to soothe irritation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: OROSEDAL oral spray (a medical device that forms a protective barrier to soothe irritation)
What this could lead to: If successful, this study could confirm that OROSEDAL provides quick pain relief for common sore throats and mouth sores without medication.
What could go wrong: This is an observational study with no placebo group, so results may be less reliable. The follow-up is only 6 days, and the device may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APHTHOUS ULCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

canker sore lichen planus, oral Oral Ulcer pharyngitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APHTHOUS ULCER MINOR MOUTH LESION ORAL LICHEN PLANUS ORAL PAIN SORE THROAT

Contacts and locations

Locations

Multiples facilities
RECRUITING

Multiple Locations, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.